On 23.02.2017, DK CHEM, in cooperation with the University of Silesia in Katowice, applied for two patents P.420626 and P.420629 regarding new selective butyrylcholinesterase inhibitors with potential use in the treatment of dementia in Alzheimers disease.
March 22, 2019 The Patent Office of the Republic of Poland granted DK CHEM and the University of Silesia patents for two inventions concerning new selective inhibitors of butyrylcholinesterases with potential application in the treatment of the effects of dementia in Alzheimers disease. The patents were approved under the numbers 232830 and 232831. https://us.edu.pl/nowe-zwiazki-w-walce-z-choroba-alzheimera/
March 2020 The company DK CHEM Organic Synthesis LTD started research on the development of a serine protease inhibitor of the SARS-CoV-2 coronavirus.
September 2021 Lecture Cathinone derivatives.